Zobrazeno 1 - 10
of 17 785
pro vyhledávání: '"Mycophenolate"'
Publikováno v:
Oman Journal of Ophthalmology, Vol 17, Iss 3, Pp 399-402 (2024)
This study outlines a scenario involving unilateral periocular inflammation exhibited resistance to conventional immunomodulatory therapy (IMT) and biologic response modifying agents, which was successfully managed with oral cyclophosphamide monother
Externí odkaz:
https://doaj.org/article/8d16d16f811f4649aa68e8815e04a44d
Publikováno v:
Biomedical and Biotechnology Research Journal, Vol 8, Iss 3, Pp 369-374 (2024)
Background: Lupus nephritis (LN) is a potentially severe complication of systemic lupus erythematosus (SLE). Mycophenolate mofetil (MMF) is an oral immunosuppressive agent used in lupus patients who are intolerant of or refractory to other convention
Externí odkaz:
https://doaj.org/article/913b748c2abe4156991513f695229546
Autor:
Gurdeep Singh Dhooria, Siddharth Bhargava, Deepak Bhat, Puneet Aulakh Pooni, Nancy Goel, Shruti Kakkar
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Introduction There is a scarcity of research comparing the efficacy of cyclophosphamide and mycophenolate mofetil in childhood nephrotic syndrome. The aim was to evaluate the efficacy and safety of oral cyclophosphamide (CYC) and mycophenola
Externí odkaz:
https://doaj.org/article/099c819e273e42f985b2650167933808
Autor:
Wallace, Daniel J., author
Publikováno v:
The Lupus Book : A Guide for Patients and Their Families, 2025.
Externí odkaz:
https://doi.org/10.1093/oso/9780197689837.003.0027
Autor:
Daniel R. Antohi, BA, Michelle Toker, BS, Suraj Muddasani, MD, Michael Occidental, MD, Bijal Amin, MD, Breanne Mordorski, MD, Benedict Wu, DO, PhD
Publikováno v:
JAAD Case Reports, Vol 53, Iss , Pp 109-111 (2024)
Externí odkaz:
https://doaj.org/article/8d47d334ea5b40398df443cfbaca34f2
Publikováno v:
International Journal of Ophthalmology, Vol 17, Iss 12, Pp 2229-2235 (2024)
AIM: To investigate the efficacy of systemic mycophenolate mofetil (MMF) as an adjunct in combination with topical tacrolimus (FK506) and corticosteroid eyedrops for preventing corneal graft rejection after high-risk keratoplasty (HRK). METHODS: In t
Externí odkaz:
https://doaj.org/article/3767767a50754f3389ad079bdb0a91c8
Publikováno v:
口腔疾病防治, Vol 32, Iss 8, Pp 614-619 (2024)
Objective To investigate the application of mycophenolate mofetil (MMF) in oral mucosal pemphigoid and provide a clinical reference. Methods One case of glucocorticoids combined with MMF in the treatment of oral mucosal pemphigoid was reported, and t
Externí odkaz:
https://doaj.org/article/2ff8db7980764eb590005fcc0551fec1
Publikováno v:
Journal of Mass Spectrometry and Advances in the Clinical Lab, Vol 33, Iss , Pp 7-13 (2024)
Background: As an active metabolite of a commonly prescribed immunosuppressant, mycophenolic acid (MPA) levels are often monitored to prevent organ rejection following a transplant. Triazoles are often prescribed for treatment of invasive fungal infe
Externí odkaz:
https://doaj.org/article/693ec4cbd4064da9ae922f3de7ff7e32
Publikováno v:
Annals of Indian Academy of Neurology, Vol 27, Iss 3, Pp 250-253 (2024)
Objective: To determine the factors, if any, that are associated with the efficacy of “off-label therapies” (OLTs) for multiple sclerosis (MS). Methods: Consecutive patients (N = 174) with relapsing–remitting MS (RRMS) or secondary progressive
Externí odkaz:
https://doaj.org/article/bcb24f12d36e4069b69bead1f7771aa8
Autor:
Kaitlyn Grieves, PharmD, Brian C. Keller, MD, PhD, Georgina Waldman, PharmD, BCTXP, Jacqueline E. Clark, PharmD, BCPS, BCTXP
Publikováno v:
JHLT Open, Vol 6, Iss , Pp 100156- (2024)
Background: Mycophenolate mofetil (MMF) is a key immunosuppression agent for lung transplant recipients (LTR); however, the side effects often lead to dose modifications. Kidney transplant literature has shown reductions in MMF dosing led to an incre
Externí odkaz:
https://doaj.org/article/657363c750f644cebfbdd315a391c486